reflecting Lilly's ongoing commitment to elevate care and improve outcomes for patients." Lilly is committed to serving patients living with Crohn's disease and is working with insurers ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and near-term payments for global rights to an asset that is ...

Health-care companies slid after a profit warning from Eli Lilly. Shares of the obesity-drug maker tumbled after it slashed its projection for fourth-quarter revenue as the market for drugs that ...

Lilies are a garden favorite because of their beautiful blooms. Learn how to care for lily bulbs in the winter and whether you should water lily bulbs in the winter.

Catherine Donnelly receives funding from Canadian Institutes of Health Research, Social Sciences and Humanities Research Council, Federal Government, Ontario Ministry of Health, Ontario Health ...

It’s been a rough month for several clinical amyotrophic lateral sclerosis (ALS) candidates, but that’s not stopping Eli Lilly from pursuing new drugs of its own for the devastating ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight ... Trump administration. Eli Lilly said Monday it would acquire ...

From mastering the watering routine to perfecting soil type, there's a reason fiddle leaf figs are one of the biggest ...

Eli Lilly (LLY) revised its revenue outlook on Tuesday for the fourth quarter of 2024 on weaker-than-expected demand for its popular weight-loss drugs, Zepbound and Mounjaro. The drugmaker said it ...